New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in
May 20 2008 - 8:15AM
PR Newswire (US)
WILMINGTON, Del., May 20 /PRNewswire-FirstCall/ -- A new open-label
study evaluated patient satisfaction with budesonide/formoterol
combination therapy and fluticasone/salmeterol combination therapy,
as measured by the Asthma Treatment Satisfaction Measure (ATSM)(1).
Patients participating in the study were ages 18 years and older
with moderate to severe asthma(1) and had been previously treated
with inhaled corticosteroids(1). Results were presented today at
the International Conference of the American Thoracic Society held
in Toronto, May 16-21, 2008. Results showed that patients receiving
budesonide/formoterol combination therapy administered as
adjustable dosage reported significantly greater satisfaction on
the ATSM overall (p=0.02) than patients receiving
fluticasone/salmeterol combination therapy, especially in the
categories of feel medication begins to work (p